Search
Member exclusive

Pine Pharmaceuticals Discontinues Avastin and Other Ophthalmic Product Manufacturing

Oct 14, 2024
Administrative Burden
Public Health & Safety
A closeup photo of a doctor's hands wearing blue latex gloves as he pulls medicine from a small bottle with a syringe

The Academy is engaging with alternative suppliers and pushing CMS to intervene on Medicare Advantage plan step therapy requirements for Avastin. 

Member exclusive

Log in to keep reading.

Join AAO to get unlimited access to content. See member benefits or join today.

Login Register